Valeo Pharma (CSE: VPH – OTCQB: VPHIF) CEO Steve Saviuk joined Steve Darling from Proactive to share details that private payer health plans, that cover about 80% of privately insured Canadians, will now provide reimbursement for Enerzair Breezhaler and Atectura Breezhaler.
Saviuk telling Proactive this a key step as Valeo prepares to begin to distribute the products.